Timing is everything for compassionate use of delamanid.
Tuberculosis Research Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
Clifton E
CE
Barry
D000995:Antitubercular Agents / Q000627:therapeutic use*; D057176:Compassionate Use Trials; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010080:Oxazoles / Q000627:therapeutic use*
D000995:Antitubercular Agents; D009593:Nitroimidazoles; D010080:Oxazoles